Dream Finders Homes $143.5 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Perion Network $66 million follow-on offering
We advised Perion, whose shares are listed on Nasdaq and the Tel Aviv Stock Exchange
Energizer Holdings $650 million incremental financing
We advised the joint lead arrangers and bookrunners on the incremental term facility
Generation Bio $225.4 million stock offering
We advised the underwriters on the public equity offering
Gracell Biotechnologies $209 million IPO and Nasdaq listing
We advised the underwriters on the IPO of ADSs
Energizer Holdings $950 million refinancing
Davis Polk advised (i) the joint lead arrangers and joint bookrunners and (ii) the administrative agent, in connection with a $550 million senior secured term loan facility and a $400…
Solid Biosciences $90 million common stock PIPE offering
Davis Polk advised the placement agent in connection with a private placement pursuant to Rule 4(a)(2) by Solid Biosciences Inc. of $90 million of common stock.
Solid Biosciences Inc…
Ormat Technologies $307 million follow-on offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $307 million public offering of 4,150,000 shares of common stock…
Veritiv secondary offering
Davis Polk advised the underwriter in connection with an SEC-registered secondary offering of 1,400,000 shares of Veritiv Corporation’s common stock by UWW Holdings, LLC. The common…
BioNTech $500 million SEC-registered at-the-market offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by BioNTech SE of its ordinary shares represented by American depositary shares for up to an…